BR112012015446A2 - composições estimulantes de paxilina e usos cosméticos dos mesmos - Google Patents

composições estimulantes de paxilina e usos cosméticos dos mesmos

Info

Publication number
BR112012015446A2
BR112012015446A2 BR112012015446-0A BR112012015446A BR112012015446A2 BR 112012015446 A2 BR112012015446 A2 BR 112012015446A2 BR 112012015446 A BR112012015446 A BR 112012015446A BR 112012015446 A2 BR112012015446 A2 BR 112012015446A2
Authority
BR
Brazil
Prior art keywords
paxillin
compositions
cosmetic uses
stimulating compositions
cosmetic
Prior art date
Application number
BR112012015446-0A
Other languages
English (en)
Other versions
BR112012015446B1 (pt
Inventor
Zheng Qian
Wyborski Russel
Santhanam Uma
W. Lyga John
Ptchelintsev Dimitri
Original Assignee
Avon Products, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Products, Inc. filed Critical Avon Products, Inc.
Publication of BR112012015446A2 publication Critical patent/BR112012015446A2/pt
Publication of BR112012015446B1 publication Critical patent/BR112012015446B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cosmetics (AREA)

Abstract

composições estimulantes de paxilina e usos cosméticos dos mesmos composições cosméticas compreendendo um ou mais estimuladores de paxilina e métodos de usar tais composições para dar benefício antienvelhecimento à pele são descritos. acredita-se que os estimuladores de paxilina e combinações dos mesmos têm atividade moduladora junto a pelo menos uma série de reação bioquímica implicada no envelheciemto da pele.
BR112012015446-0A 2009-12-22 2010-12-13 Composição tópica e método para conferir um benefício antienvelhecimento à pele BR112012015446B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US28903809P 2009-12-22 2009-12-22
US61/289,038 2009-12-22
US29072009P 2009-12-29 2009-12-29
US61/290,720 2009-12-29
PCT/US2010/060012 WO2011087654A1 (en) 2009-12-22 2010-12-13 Paxillin stimulating compositions and cosmetic uses thereof

Publications (2)

Publication Number Publication Date
BR112012015446A2 true BR112012015446A2 (pt) 2018-12-18
BR112012015446B1 BR112012015446B1 (pt) 2020-02-11

Family

ID=44151461

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012015446-0A BR112012015446B1 (pt) 2009-12-22 2010-12-13 Composição tópica e método para conferir um benefício antienvelhecimento à pele

Country Status (10)

Country Link
US (3) US8394427B2 (pt)
EP (1) EP2516429B1 (pt)
JP (1) JP2013515054A (pt)
CN (2) CN103119041A (pt)
AR (1) AR079578A1 (pt)
BR (1) BR112012015446B1 (pt)
CA (1) CA2784895C (pt)
MX (3) MX2012007256A (pt)
TW (2) TWI642448B (pt)
WO (1) WO2011087654A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011087654A1 (en) 2009-12-22 2011-07-21 Avon Products, Inc. Paxillin stimulating compositions and cosmetic uses thereof
US20110159125A1 (en) 2009-12-29 2011-06-30 Avon Products, Inc. CGRP Compositions and Uses Thereof
MX2012013787A (es) 2010-06-30 2012-12-17 Avon Prod Inc Composiciones y metodos para estimular magp-1 y mejorar la apariencia de la piel.
WO2012091832A2 (en) * 2010-12-30 2012-07-05 Avon Products, Inc. Modulation of dynein in skin
US10195136B2 (en) 2011-08-24 2019-02-05 Avon Products, Inc. Collagen and elastin stimulating compositions and uses thereof
DE102012210384A1 (de) * 2012-06-20 2014-05-22 Beiersdorf Ag Kosmetische und dermatologische Zubereitung enthaltend eine oder mehrere Substanz(en), die das Gen / Protein für den Rezeptor Endo180 modulieren
US9168283B2 (en) 2012-12-11 2015-10-27 Avon Products, Inc. Medemia nobilis extracts and methods of use
TW201422246A (zh) 2012-12-11 2014-06-16 Avon Prod Inc 藉由調節ｗｉｐｉ－１改善皮膚老化外觀之方法
WO2015168524A1 (en) * 2014-05-02 2015-11-05 Choi Minkyung Grace Device and method for producing a customized cosmetic composition
JP2016196428A (ja) * 2015-04-03 2016-11-24 株式会社ダイセル エクオール及びキレート剤を含有する外用組成物
US20170152556A1 (en) * 2015-06-08 2017-06-01 The Procter & Gamble Company Methods for identifying circadian rhythm-dependent cosmetic agents for skin care compositions
JP6864094B2 (ja) * 2016-12-13 2021-04-21 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ レチノイドを含有する安定したパーソナルケア組成物
JP6978015B1 (ja) * 2020-06-29 2021-12-08 徹 中西 Ｃｃｎ１及びｃｃｎ２の発現を増加させるための皮膚適用用組成物

Family Cites Families (122)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE505253A (pt) * 1950-08-23
JPS4822638B1 (pt) 1964-10-16 1973-07-07
US4122029A (en) 1977-07-27 1978-10-24 Dow Corning Corporation Emulsion compositions comprising a siloxane-oxyalkylene copolymer and an organic surfactant
JP2622955B2 (ja) 1986-07-29 1997-06-25 エイボン プロダクツ インコ−ポレイテツド 無水化粧品
US4781917A (en) 1987-06-26 1988-11-01 The Proctor & Gamble Company Antiperspirant gel stick
JPH0314596A (ja) * 1989-06-12 1991-01-23 Horiuchiitarou Shoten:Kk アントシアニン及びその塩
JPH07119175B2 (ja) * 1989-06-26 1995-12-20 博隆 伊藤 アレルギー性鼻炎薬
JPH0558874A (ja) * 1991-09-03 1993-03-09 Besubio:Kk 皮膚化粧料
TW233264B (pt) 1992-02-03 1994-11-01 Otsuka Pharma Co Ltd
JPH05317016A (ja) * 1992-05-15 1993-12-03 Tanabe Seiyaku Co Ltd 天然酸化防止剤
US5242916A (en) 1992-07-07 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
FR2730408B1 (fr) 1995-02-09 1997-09-05 Hanna Claude Compositions a activite depigmentante ainsi que leurs applications
WO1997027838A1 (en) 1996-02-02 1997-08-07 Estee Lauder, Inc. Skin smoothing compositions containing hydroxyacids and methods for using same
US5885595A (en) 1996-05-13 1999-03-23 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic composition with a retinol fatty acid ester
JPH1017460A (ja) * 1996-06-28 1998-01-20 Shiseido Co Ltd 抗老化剤
TR199900610T2 (xx) 1996-09-20 1999-06-21 The Howard Foundation Polifenol i�eren terkiplerin �retim y�ntemi.
AUPO316796A0 (en) * 1996-10-23 1996-11-14 Hood, John James David Essential oil
ES2264169T3 (es) 1996-10-30 2006-12-16 Pfizer Inc. Derivados azabiciclicos de piridona fusionada o de citisina, su preparacion y su uso en la terapia de adiccion.
US6087322A (en) 1997-04-24 2000-07-11 The Procter & Gamble Company Fragrance pro-accords
US20020132021A1 (en) 1997-04-30 2002-09-19 Ilya Raskin Elicited plant products
JPH1192331A (ja) * 1997-09-22 1999-04-06 Shiseido Co Ltd 皮膚外用剤
JPH11246337A (ja) * 1998-03-03 1999-09-14 Shiseido Co Ltd 抗老化剤
US6146640A (en) 1998-08-31 2000-11-14 Dyke; John Paul Immune system catalyst
JP3727179B2 (ja) 1998-09-21 2005-12-14 日立機材株式会社 ブロックチェン
JP2000095663A (ja) 1998-09-24 2000-04-04 Kose Corp 植物抽出物を含有する外用剤
JP4280340B2 (ja) 1998-10-28 2009-06-17 一丸ファルコス株式会社 保湿性植物抽出物を含有する化粧料組成物
JP2000178168A (ja) * 1998-12-18 2000-06-27 Ichimaru Pharcos Co Ltd エラスターゼ活性阻害剤及び化粧料組成物
EP1145707A4 (en) 1999-01-28 2005-08-31 Shiseido Co Ltd COMPOSITIONS FOR OUTSIDE USE
US7108982B1 (en) 1999-02-19 2006-09-19 University Of Iowa Research Foundation Diagnostics and the therapeutics for macular degeneration
DE19910704B4 (de) 1999-03-10 2006-04-20 Cognis Ip Management Gmbh Kosmetische Zubereitungen und deren Verwendung
JP2000297291A (ja) * 1999-04-15 2000-10-24 Univ Kinki 香気成分、その製造法および用途
JP2000302634A (ja) * 1999-04-27 2000-10-31 Ichimaru Pharcos Co Ltd 化粧料組成物
JP2001002575A (ja) * 1999-06-21 2001-01-09 Sunstar Inc メラニン産生促進剤
US6685952B1 (en) 1999-06-25 2004-02-03 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal care compositions and methods-high internal phase water-in-volatile silicone oil systems
US6143303A (en) 1999-08-14 2000-11-07 Janakiram; Chodavarapu Analgesic anti-inflammatory composition and method of preparing from dodonaea sp
US6264939B1 (en) 1999-10-21 2001-07-24 The United States Of America, As Represented By The Secretary Of Agriculture Bisexual attractants, aggregants and arrestants for adults and larvae of codling moth and other species of lepidoptera
JP2001278783A (ja) * 2000-03-29 2001-10-10 Shiseido Co Ltd コラーゲン産生促進剤
CN1322830A (zh) * 2000-05-09 2001-11-21 上海博德基因开发有限公司 一种新的多肽——人粘着斑激酶(fak)13和编码这种多肽的多核苷酸
DE10028764A1 (de) 2000-06-09 2001-12-20 Henkel Kgaa Urethane basierend auf organoleptisch aktiven Duftalkoholen
JP4532706B2 (ja) 2000-09-08 2010-08-25 花王株式会社 化粧料
US6583184B1 (en) 2000-11-27 2003-06-24 Avon Products, Inc. Compositions having comfrey and methods for reducing retinoid-induced skin irritation
JP4880816B2 (ja) 2000-12-15 2012-02-22 株式会社ヤクルト本社 皮膚老化防止剤
US20040067245A1 (en) * 2000-12-20 2004-04-08 Harish Mahalingam Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
US20030032771A1 (en) 2001-02-14 2003-02-13 Sharp David J. Peptide inhibitors of cellular proliferation
JP4324465B2 (ja) * 2001-06-12 2009-09-02 久光製薬株式会社 シート状貼付剤
JP4901025B2 (ja) * 2001-06-22 2012-03-21 株式会社ナリス化粧品 エラスターゼ阻害剤
JP2003113064A (ja) 2001-09-28 2003-04-18 Ts Aasu:Kk 皮膚外用剤
JP3709363B2 (ja) * 2001-10-09 2005-10-26 ポーラ化成工業株式会社 メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料
JP4587200B2 (ja) * 2001-10-09 2010-11-24 株式会社ファンケル グルタチオン増強用組成物
US20030091665A1 (en) * 2001-11-09 2003-05-15 Avon Products, Inc Topical cosmetic composition with skin rejuvenation benefits
US7101633B2 (en) 2002-03-06 2006-09-05 Tdk Corporation Electroplated magnetic thin film, method of manufacturing the same, electroplating bath and thin film magnetic head
US6884783B2 (en) * 2002-05-03 2005-04-26 Unigen Pharmaceuticals, Inc. 7-Hydroxy chromones as potent antioxidants
JP2003342184A (ja) * 2002-05-31 2003-12-03 Ichimaru Pharcos Co Ltd ヒアルロニダーゼ活性阻害剤及び化粧料組成物
DE10231468A1 (de) 2002-07-08 2004-02-26 Coty B.V. Anti-Hautalterungskosmetikum
JP2004051492A (ja) * 2002-07-16 2004-02-19 Kose Corp 老化防止剤又は細胞賦活剤及びこれを含有する皮膚外用剤
US20070010657A1 (en) 2002-09-13 2007-01-11 Rainer Klocke Cytoplasmic dynein heavy chain 1 genes, expression products, non-human animal model uses in human neurological diseases
WO2004026249A2 (en) 2002-09-20 2004-04-01 The General Hospital Corporation Methods and compositions for preventing skin damage
CA2499602A1 (en) 2002-09-23 2004-04-01 Graham Edmund Kelly Skin photoageing and actinic damage treatment
GB0226270D0 (en) * 2002-11-11 2002-12-18 Unilever Plc Method of producing retinyl esters
GB2400034B (en) 2003-03-29 2005-10-26 Agrisense Bcs Ltd Insect control system
JP2004331635A (ja) * 2003-05-04 2004-11-25 Kaicho Se 細胞遣伝情報正常化材料及びその製法
CN1596730A (zh) * 2003-09-19 2005-03-23 东洋油墨制造株式会社 蝶豆花提取物和糖类成分提取物的制造方法
US7758878B2 (en) * 2003-10-10 2010-07-20 Access Business Group International Llc Cosmetic treatment system and methods
CN1262267C (zh) * 2003-11-14 2006-07-05 刘贤英 一种中药祛斑美白保健品及其制备工艺
US7579495B2 (en) * 2003-12-19 2009-08-25 Momentive Performance Materials Inc. Active-releasing cyclic siloxanes
KR20050068068A (ko) 2003-12-29 2005-07-05 학교법인 백암교육재단 버섯 및 장뇌삼 추출물을 함유하는 화장료 조성물
KR20050068588A (ko) * 2003-12-30 2005-07-05 주식회사 엘지생활건강 가려움증 완화 화장료 조성물
CA2495839A1 (en) 2004-02-04 2005-08-04 Omboon Luanratana Anti-photoaging cosmeceutical composition
US20050196450A1 (en) 2004-03-04 2005-09-08 Elka Touitou Method and composition for burned skin
CA2564399A1 (en) 2004-04-28 2005-11-17 Brigham Young University Use of equol for treating skin diseases
JP5128277B2 (ja) 2004-05-28 2013-01-23 ユニジェン・インコーポレーテッド 二核酵素の強力な阻害剤としてのジアリールアルカン類
FR2871061B1 (fr) 2004-06-04 2007-08-10 Coletica Sa Principe actif capable d'induire la transformation du tgbf- latent inactif en tgfb actif
EP2287329A3 (en) 2004-07-09 2011-08-03 University of Pittsburgh of the Commonwealth System of Higher Education Identification of markers in esophageal cancer
US20060024390A1 (en) 2004-07-27 2006-02-02 Alex Schauss Palm fiber-based dietary supplements
JP5041569B2 (ja) 2004-09-01 2012-10-03 丸善製薬株式会社 チロシナーゼ活性阻害剤、美白剤及び皮膚化粧料
JP2006095182A (ja) * 2004-09-30 2006-04-13 Green:Kk 天然物抽出清浄剤
US7618662B2 (en) 2004-12-22 2009-11-17 Avon Products, Inc Use of natural plant extracts in cosmetic compositions
US8221766B2 (en) 2004-12-22 2012-07-17 Avon Products, Inc. Use of plant extracts to prevent and/or reduce the signs of subjective discomfort and/or irritation in the topical application of cosmetic products
KR101154616B1 (ko) 2004-12-31 2012-06-08 (주)아모레퍼시픽 캄페롤 및 퀘르세틴을 함유하는 히알루론산 생성 촉진용조성물
US20070071780A1 (en) 2005-06-16 2007-03-29 Dubois Zerlina G Personal care composition comprising a perfume booster accord
JP2007016003A (ja) * 2005-07-11 2007-01-25 Toyo Ink Mfg Co Ltd 抗酸化剤
DE102005043188A1 (de) * 2005-09-09 2007-03-22 Henkel Kgaa Verbrauchsprodukte mit wechselnden Geruchsbildern
BRPI0504517A (pt) 2005-10-20 2007-09-25 Univ Estadual Paulista Julio D uso, na modulação dos sistemas colinérgico e/ou serotonérgico e/ou gabaérgico de vertebrados, de um extrator bruto vegetal padronizado, composição farmacêutica para o tratamento de distúrbios associados a disfunções do sistema colinérgico e/ou serotonérgico e/ou gabaérgico, e processo de produção de medicamento para a modulação dos sistemas colinérgico e/ou serotonérgico e/ou gabaérgico de vertebrados
AU2007207675B2 (en) 2006-01-13 2013-01-31 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production with tanshinones
WO2007093839A1 (en) 2006-02-16 2007-08-23 Sederma New polypeptides kxk and their use
JP2007291031A (ja) * 2006-04-26 2007-11-08 Shiseido Co Ltd 抗酸化香料組成物及びこれを含有する皮膚外用剤
EP2018148A2 (en) 2006-05-15 2009-01-28 The Procter and Gamble Company Method of enhancing penetration of water-soluble actives
KR20070111635A (ko) 2006-05-18 2007-11-22 주식회사 코리아나화장품 먼나무 추출물을 유효성분으로 함유하는 주름개선용 화장료조성물
CN1895213A (zh) * 2006-05-31 2007-01-17 于钧 一种枸杞清洁、护理组合物
US20080119433A1 (en) 2006-07-06 2008-05-22 Aaron Thomas Tabor Compositions and Methods for Genetic Modification of Cells Having Cosmetic Function to Enhance Cosmetic Appearance
CN101143166B (zh) * 2006-09-13 2011-02-02 广东中大南海海洋生物技术工程中心有限公司 消肿止痛的药物及其制备方法与应用
CN100475189C (zh) 2006-10-17 2009-04-08 王海龙 一种化妆品组合物及其制备方法和应用
WO2008073684A1 (en) 2006-12-08 2008-06-19 Lipo Chemicals Inc. Composition for treating aging skin comprising a hydroxycinnamic acid such as p-coumaric acid
KR100893162B1 (ko) * 2007-02-21 2009-04-17 바이오스펙트럼 주식회사 카바크롤을 유효성분으로 포함하는 피부주름 개선제
JP2008255020A (ja) * 2007-04-02 2008-10-23 Fujifilm Corp 抗老化皮膚外用剤
US7700110B2 (en) 2007-05-22 2010-04-20 Access Business Group International Llc Skin firming and lifting compositions and methods of use
JP2009013128A (ja) * 2007-07-06 2009-01-22 Sosin:Kk 皮膚外用剤及び口腔用組成物
EP2067467A3 (en) 2007-09-14 2012-12-12 L'Oréal Compositions and methods for treating keratinous substrates
KR100999261B1 (ko) 2007-10-09 2010-12-07 (주)아모레퍼시픽 여성호르몬 결핍으로 초래되는 여성 피부의 노화 억제제 스크리닝 방법
EP2240192A4 (en) 2008-01-07 2013-02-27 Robert Alan Armstrong TREATMENT OF DERMATOLOGICAL SUFFERING
JP5282340B2 (ja) * 2008-03-13 2013-09-04 長岡香料株式会社 天然素材の抗酸化作用および／またはリパーゼ阻害活性を増強させる方法、ならびに当該活性が増強された天然素材
JP2010090069A (ja) 2008-10-09 2010-04-22 Shiseido Co Ltd 美白剤および皮膚外用剤
FR2939316B1 (fr) 2008-12-05 2012-08-10 Limousine D Applic Biolog Ditesilab Soc Ind Utilisation cosmetique d'activateurs de l'autophagie des cellules cutanees.
US7993629B2 (en) * 2008-12-23 2011-08-09 Avon Products, Inc. Topical compositions containing CIS-6-nonenol and its derivatives and methods for treating skin
US7592024B1 (en) 2008-12-29 2009-09-22 Avon Products, Inc. Topical compositions containing melicope hayselii and a method of treating skin
CN101559033A (zh) 2009-05-20 2009-10-21 黎秋萍 草药花泡沫沐浴剂与护肤胶囊
JP2009197035A (ja) * 2009-06-11 2009-09-03 Tsujido Chemical Corp 皮膚外用剤
US20110044920A1 (en) 2009-08-07 2011-02-24 Mary Kay Inc. Topical skin care formulations
WO2011087654A1 (en) 2009-12-22 2011-07-21 Avon Products, Inc. Paxillin stimulating compositions and cosmetic uses thereof
US20110159125A1 (en) 2009-12-29 2011-06-30 Avon Products, Inc. CGRP Compositions and Uses Thereof
WO2011156136A1 (en) * 2010-06-11 2011-12-15 Avon Products, Inc. Use of eclipta prostrata and other ppar-gamma inhibitors in cosmetics and compositions thereof
US8771758B2 (en) 2010-06-30 2014-07-08 Avon Products, Inc. Use of Tiliacora triandra in cosmetics and compositions thereof
US8815265B2 (en) 2010-06-30 2014-08-26 Avon Products, Inc. Cosmetic use of N-substituted sulfonyloxybenzylamines and related compounds
MX2012013787A (es) 2010-06-30 2012-12-17 Avon Prod Inc Composiciones y metodos para estimular magp-1 y mejorar la apariencia de la piel.
US8686013B2 (en) 2011-08-25 2014-04-01 Avon Products, Inc. Cosmetic use of substituted amino heterocylic carbamoyl analogs and related compounds
US9289365B2 (en) 2011-10-24 2016-03-22 Avon Products, Inc. Compositions and methods for stimulating collagen synthesis in the skin
WO2013090228A2 (en) 2011-12-13 2013-06-20 Avon Products, Inc. Maesa japonica extracts and methods of use
US8632827B2 (en) 2011-12-13 2014-01-21 Avon Products, Inc Modulation of thymosin beta-4 in skin
JP2012246324A (ja) * 2012-09-18 2012-12-13 Sosin:Kk 皮膚外用剤
US9186316B2 (en) 2012-12-11 2015-11-17 Avon Products, Inc. Stephanotis jasminoides extracts and methods of use
US9034396B2 (en) 2012-12-11 2015-05-19 Avon Products, Inc. Serissa japonica extracts and methods of use
TW201422246A (zh) 2012-12-11 2014-06-16 Avon Prod Inc 藉由調節ｗｉｐｉ－１改善皮膚老化外觀之方法

Also Published As

Publication number Publication date
EP2516429B1 (en) 2020-06-24
WO2011087654A1 (en) 2011-07-21
MX339842B (es) 2016-06-14
CA2784895C (en) 2018-07-17
AR079578A1 (es) 2012-02-01
US20110151029A1 (en) 2011-06-23
JP2013515054A (ja) 2013-05-02
EP2516429A1 (en) 2012-10-31
CN106367478A (zh) 2017-02-01
TW201136614A (en) 2011-11-01
EP2516429A4 (en) 2014-06-25
US20150202146A1 (en) 2015-07-23
US20120328546A1 (en) 2012-12-27
CN103119041A (zh) 2013-05-22
TW201601775A (zh) 2016-01-16
BR112012015446B1 (pt) 2020-02-11
US10251831B2 (en) 2019-04-09
TWI642448B (zh) 2018-12-01
CA2784895A1 (en) 2011-07-21
US8394427B2 (en) 2013-03-12
TWI511750B (zh) 2015-12-11
MX2012007256A (es) 2013-01-29
US9066896B2 (en) 2015-06-30
MX368365B (es) 2019-09-30

Similar Documents

Publication Publication Date Title
BR112012015446A2 (pt) composições estimulantes de paxilina e usos cosméticos dos mesmos
BR112012028648A2 (pt) uso cosmético de sulfoniloxibenzilaminas substituídas por n e compostos relacionados
BR112013016935A2 (pt) modulação da dineína na pele
BR112016004095A2 (pt) administração de enzimas de empobrecimento de quinurenina para a terapia contra tumores
BRPI0915300C1 (pt) compostos de éster boronato e composições farmacêuticas dos mesmos
BR112014029099A2 (pt) anticorpos anti-egfr e seu uso para inibir ou atenuar crescimento de tumor, bem como composição farmacêutica que o compreende
UA107812C2 (en) Oktahidropirolo disubstituted [3,4-c] pyrrole receptors as orexin modulators
BR112013007862A2 (pt) ácidos nucleicos manipulados e métodos de uso dos mesmos.
BR112012010010A2 (pt) piridinas bicíclicas e análogos como moduladores da sirtuína
BR112016022455A2 (pt) Uso de um sobrenadante de culturas de uma cepa de espécies de bacillus pumilus, composição cosmética ou dermofarmacêutica não natural, e, método não terapêutico para aumentar os níveis de adiponectina, aumentar a atividade mitocondrial no músculo, aumentar a resistência muscular e/ou repitelização da pele, estimular a síntese de colágeno e/ou a síntese de ácido hialurônico, tratamento de endurecimento da pele e/ou prevenção da perda de firmeza da pele
BRPI0511139A (pt) compostos, composição farmacêutica que compreende os mesmos, método para inibir atividade de quinase aurora em uma célula e método para tratamento de um distúrbio mediado por quinase aurora em um paciente
AR093217A1 (es) Anticuerpos antagonistas mejorados contra factor-8 de crecimiento y diferenciacion y usos de los mismos
BR112015023203A2 (pt) métodos para tratamento de câncer, para aumentar a eficiência de um tratamento de câncer, para retardar e/ou prevenir o desenvolvimento de câncer, para tratar um indivíduo com câncer, para aumentar a sensibilidade para um agente de terapia para câncer, para estender um período de sensibilidade e para estender a duração da resposta para uma terapia para câncer, e usos
BR112016002753A2 (pt) anticorpos contra o inibidor-1 de ativador de plasminogênio (pai-1) e usos dos mesmos
BR112012028802A2 (pt) composições contendo enzima de reparo de dna e extrato de anogeissus
BR112015023987A2 (pt) creme dental de duas fases
BR112014006455A2 (pt) alquilamidotiazóis, preparações cosméticas ou dermatológicas com um teor de um ou vários alquilamidotiazóis e uso de um ou vários alquilamidotiazóis
BR112015013046A2 (pt) composição comestível, método de redução da amplitude do pico de glicose pós-prandial no sangue ou resposta glicêmica em uma pessoa diabética ou não diabética, método para tratar uma pessoa em necessidade deste para diabetes tipo 2 e uso de uma composição
EA201190168A1 (ru) Терапевтические применения фракций мастиковой смолы
BR112012024630B8 (pt) Processos para o tratamento cosmético de envelhecimento da pele
CL2011002160A1 (es) Compuestos derivados de 3-amino-2-mercaptoquinolinas sustituidas; composicion farmaceutica que contiene dichos compuestos; y su uso para tratar dolor, epilepsis, incontinencia urinaria, manias, migraña, trastornos bipolares, enfermedades cognitivas, discinesia asociada a la distonia y/o incontinencia urinaria.
GB201202561D0 (en) Treatment of skin disorders
BR112012008638A2 (pt) Método para melhorar a aparência dos cílios e o número de cílios visíveis sobre uma pálpebra, composição tópica e kit
BR112016006321A2 (pt) enzima engenheirada tendo atividade aceto acetil-coa hidrolase, micro-organismos compreendendo a mesma, e processos de uso da mesma
AR082277A1 (es) Composicion de moleculas pequeñas con actividad lipolitica y antiadipogenica

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority

Free format text: PERDA DAS PRIORIDADES US61/289,038 DE 22/12/2009 E US61/290,720 DE 29/12/2009 POR NAO CUMPRIMENTO DE EXIGENCIA. FOI SOLICITADO A APRESENTACAO DE DOCUMENTO DE CESSAO CONTENDO OS NUMEROS DAS PRIORIDADES. EM RESPOSTA, O REQUERENTE APRESENTOU UM DOCUMENTO DE CESSAO DE UM DEPOSITO DE PATENTE AMERICANO QUE REIVINDICA AS MESMAS PRIORIDADES, POREM, DE ACORDO COM A RESOLUCAO 179 DE 2017, O DOCUMENTO DE CESSAO DEVE CONTER O NUMERO DA PRIORIDADE REIVINDICADA.

B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C07D 471/00 , C07D 471/18 , A61K 31/437

Ipc: A61K 8/34 (2006.01), A61K 8/49 (2006.01), A61K 8/9

B12F Appeal: other appeals
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application according art. 36 industrial patent law
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application according art. 36 industrial patent law
B09A Decision: intention to grant
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/12/2010, OBSERVADAS AS CONDICOES LEGAIS.